annual CFO:
-$142.11M-$65.35M(-85.13%)Summary
- As of today (August 29, 2025), SMMT annual cash flow from operations is -$142.11 million, with the most recent change of -$65.35 million (-85.13%) on December 31, 2024.
- During the last 3 years, SMMT annual CFO has fallen by -$69.52 million (-95.77%).
- SMMT annual CFO is now -977.53% below its all-time high of $16.19 million, reached on January 31, 2017.
Performance
SMMT Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$70.59M-$9.43M(-15.41%)Summary
- As of today (August 29, 2025), SMMT quarterly cash flow from operations is -$70.59 million, with the most recent change of -$9.43 million (-15.41%) on June 30, 2025.
- Over the past year, SMMT quarterly CFO has dropped by -$37.74 million (-114.90%).
- SMMT quarterly CFO is now -294.72% below its all-time high of $36.25 million, reached on October 31, 2016.
Performance
SMMT quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$211.30M-$37.74M(-21.75%)Summary
- As of today (August 29, 2025), SMMT TTM cash flow from operations is -$211.30 million, with the most recent change of -$37.74 million (-21.75%) on June 30, 2025.
- Over the past year, SMMT TTM CFO has dropped by -$114.76 million (-118.86%).
- SMMT TTM CFO is now -797.74% below its all-time high of $30.28 million, reached on July 31, 2017.
Performance
SMMT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SMMT Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -85.1% | -114.9% | -118.9% |
| 3 y3 years | -95.8% | -292.6% | -210.8% |
| 5 y5 years | -611.2% | -383.7% | -812.5% |
SMMT Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -241.8% | at low | -1851.5% | at low | -526.5% | at low |
| 5 y | 5-year | -611.2% | at low | -1851.5% | at low | -812.5% | at low |
| alltime | all time | -977.5% | at low | -294.7% | at low | -797.7% | at low |
SMMT Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$70.59M(+15.4%) | -$211.30M(+21.7%) |
| Mar 2025 | - | -$61.17M(+29.3%) | -$173.56M(+21.8%) |
| Dec 2024 | -$142.11M(+85.1%) | -$47.30M(+46.7%) | -$142.53M(+25.7%) |
| Sep 2024 | - | -$32.24M(-1.8%) | -$113.42M(+17.5%) |
| Jun 2024 | - | -$32.85M(+9.0%) | -$96.55M(+3.1%) |
| Mar 2024 | - | -$30.13M(+65.7%) | -$93.61M(+22.2%) |
| Dec 2023 | -$76.76M(+84.6%) | -$18.19M(+18.3%) | -$76.61M(+40.9%) |
| Sep 2023 | - | -$15.37M(-48.6%) | -$54.39M(+19.1%) |
| Jun 2023 | - | -$29.92M(+127.8%) | -$45.66M(+35.4%) |
| Mar 2023 | - | -$13.13M(-425.8%) | -$33.73M(-14.8%) |
| Dec 2022 | -$41.58M(-42.7%) | $4.03M(-160.7%) | -$39.60M(-23.1%) |
| Sep 2022 | - | -$6.64M(-63.1%) | -$51.47M(-24.3%) |
| Jun 2022 | - | -$17.98M(-5.4%) | -$67.99M(-2.1%) |
| Mar 2022 | - | -$19.00M(+142.1%) | -$69.46M(-2.3%) |
| Dec 2021 | -$72.59M(+50.9%) | -$7.85M(-66.1%) | -$71.13M(-1.4%) |
| Sep 2021 | - | -$23.16M(+19.0%) | -$72.13M(+8.4%) |
| Jun 2021 | - | -$19.46M(-5.9%) | -$66.51M(+7.9%) |
| Mar 2021 | - | -$20.67M(+133.7%) | -$61.65M(+24.4%) |
| Dec 2020 | -$48.11M(+140.8%) | - | - |
| Dec 2020 | - | -$8.84M(-49.6%) | -$49.54M(+21.7%) |
| Sep 2020 | - | -$17.54M(+20.2%) | -$40.70M(+75.7%) |
| Jun 2020 | - | -$14.60M(+70.5%) | -$23.16M(+170.5%) |
| Mar 2020 | - | -$8.56M(+52.1%) | -$8.56M(-75.1%) |
| Dec 2019 | -$19.98M(+4.7%) | - | - |
| Jan 2019 | - | -$5.63M(+12.8%) | -$34.36M(-6.7%) |
| Oct 2018 | - | -$4.99M(-64.3%) | -$36.82M(-19.1%) |
| Jul 2018 | - | -$14.00M(+43.7%) | -$45.52M(+132.3%) |
| Apr 2018 | - | -$9.74M(+20.4%) | -$19.60M(-0.9%) |
| Jan 2018 | -$19.08M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2018 | - | -$8.09M(-40.9%) | -$19.78M(+0.6%) |
| Oct 2017 | - | -$13.69M(-214.8%) | -$19.67M(-164.9%) |
| Jul 2017 | - | $11.93M(-220.2%) | $30.28M(+112.5%) |
| Apr 2017 | - | -$9.93M(+24.5%) | $14.25M(-5.5%) |
| Jan 2017 | $16.19M(-162.1%) | - | - |
| Jan 2017 | - | -$7.97M(-122.0%) | $15.09M(+2.1%) |
| Oct 2016 | - | $36.25M(-983.3%) | $14.77M(-153.0%) |
| Jul 2016 | - | -$4.10M(-54.9%) | -$27.89M(-3.0%) |
| Apr 2016 | - | -$9.09M(+9.7%) | -$28.75M(+12.9%) |
| Jan 2016 | -$26.10M(+41.6%) | - | - |
| Jan 2016 | - | -$8.28M(+29.3%) | -$25.47M(+17.6%) |
| Oct 2015 | - | -$6.41M(+29.0%) | -$21.65M(+17.6%) |
| Jul 2015 | - | -$4.96M(-14.6%) | -$18.41M(-7.9%) |
| Apr 2015 | - | -$5.81M(+30.3%) | -$19.99M(+20.5%) |
| Jan 2015 | -$18.43M(+100.7%) | - | - |
| Jan 2015 | - | -$4.46M(+41.1%) | -$16.59M(+36.8%) |
| Oct 2014 | - | -$3.16M(-51.6%) | -$12.12M(+35.3%) |
| Jul 2014 | - | -$6.54M(+170.8%) | -$8.96M(+270.8%) |
| Apr 2014 | - | -$2.42M | -$2.42M |
| Jan 2014 | -$9.18M(+82.1%) | - | - |
| Jan 2013 | -$5.04M(+30.6%) | - | - |
| Jan 2012 | -$3.86M(-8.1%) | - | - |
| Jan 2011 | -$4.20M(-15.5%) | - | - |
| Jan 2010 | -$4.97M(-71.9%) | - | - |
| Jan 2009 | -$17.68M(+20.4%) | - | - |
| Jan 2008 | -$14.69M(+251.9%) | - | - |
| Jan 2007 | -$4.17M(+153.4%) | - | - |
| Jan 2006 | -$1.65M(-3041.6%) | - | - |
| Jan 2005 | $56.00K(-147.3%) | - | - |
| Jan 2004 | -$118.40K | - | - |
FAQ
- What is Summit Therapeutics Inc. annual cash flow from operations?
- What is the all time high annual CFO for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. annual CFO year-on-year change?
- What is Summit Therapeutics Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. quarterly CFO year-on-year change?
- What is Summit Therapeutics Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. TTM CFO year-on-year change?
What is Summit Therapeutics Inc. annual cash flow from operations?
The current annual CFO of SMMT is -$142.11M
What is the all time high annual CFO for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high annual cash flow from operations is $16.19M
What is Summit Therapeutics Inc. annual CFO year-on-year change?
Over the past year, SMMT annual cash flow from operations has changed by -$65.35M (-85.13%)
What is Summit Therapeutics Inc. quarterly cash flow from operations?
The current quarterly CFO of SMMT is -$70.59M
What is the all time high quarterly CFO for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high quarterly cash flow from operations is $36.25M
What is Summit Therapeutics Inc. quarterly CFO year-on-year change?
Over the past year, SMMT quarterly cash flow from operations has changed by -$37.74M (-114.90%)
What is Summit Therapeutics Inc. TTM cash flow from operations?
The current TTM CFO of SMMT is -$211.30M
What is the all time high TTM CFO for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high TTM cash flow from operations is $30.28M
What is Summit Therapeutics Inc. TTM CFO year-on-year change?
Over the past year, SMMT TTM cash flow from operations has changed by -$114.76M (-118.86%)